Neurology

Pharma News and Updates for Cingulate, Merck, Transcenta, Ipsen, Nuance

Notizia - Recent Pharma, Healthcare and Biotech Happenings

Ipsen’s Cabometyx Rejected by NICE; Vertex and CRISPR Therapeutics’s Submit BLA to the FDA for exa-cel; Orphan Drug Designation to Osemitamab for Pancreatic Cancer; FDA Clears Keytruda/Padcev for Bladder and Urothelial Cancer; Cingulate Completes Trial of CTx-1301 for ADHD; Nuance Pharma Announces Dosing of First Patient in ENHANCE Trial

FDA Grants Orphan Drug Designation to Osemitamab for Pancreatic Cancer Transcenta Holding Limited has announced that the U.S. Food and Drug Administration (FDA) has awarded Orphan Drug Designation to Osemitamab (TST001), a highly potent humanized monoclonal antibody that enhances ADCC (antibody-dependent cell-mediated cytotoxicity), for treating pancreatic cancer patients. This marks the second time Osemitamab (TST001) has received Orphan Drug Designation, with its first designation being in 2021 for treating gastric cancer and gastroesophageal junction cancer. Orphan drugs are intended for the prevention, treatment, and diagnosis of uncommon diseases. The US FD...

Explore More...

medtech-news-updates-for-iotamotion-recor-natera-boston-scientific

Amber Implants VCFix spinal system; iotaMotion’s iotaSOFT Insertion System; Boston Scientific acquires Baylis; ReCor’s Paradise Ultrasound Renal Denervation; Boston Scientific’s Ranger Drug-Coated Balloon; Natera’s Prospera

myasthenia-gravis-treatment-market-growth-size-therapies-forecast-and-key-companies

Exploring the Market Potential of the Upcoming Therapies for the Myasthenia Gravis

medtech-happenings-for-neurolief-paige-bionaut-retina-medtronic

RETINA-AI Health declares positive results; Medtronic’s Hugo robotic-assisted surgery system; Boston Scientific acquires Devoro Medical; Paige obtains first-ever FDA approval

pharma-biotech-news-updates-for-innovent-biohaven-delix-intracellular-therapies

UNION Therapeutics-Innovent’s collaboration; Delix Therapeutics bags $ 70 M; Biohaven’s Verdiperstat clinical trial result; Intra-Cellular’s CAPLYTA Phase III study

west-syndrome-market-epidemiology-therapies-treatment-therapeutics-cagr-trends-size-share-growth

Scrutinizing the West Syndrome Market Space from Growth Perspectives

pharma-happenings-for-amylyx-beigene-roche-temedic-sage-therapeutics

FDA’s New Drug Application to ALS Drug; Approval to BeiGene’s Brukinsa; Roche, Temedica Forges Digital Companionship, Shares of Sage Therapeutics Rises

pharma-news-updates-for-roche-mayo-clinic-owlstone-transmedics-google

Roche inks $3B deal; Owlstone raises $58M; FDA approves OCS heart system; Google, Mayo Clinic build brain-mapping AI algorithm

recent-pharma-news-and-updates-for-Pfizer-Forte-Biosciences- Bone-Therapeutics-Versanis-Bio-AC-Immune

Pfizer’s RSV Vaccine; Forte Biosciences’ Atopic Dermatitis Asset; Bone Therapeutics’ Osteoarthritis Programme; JandJ’s HIV Vaccine Trial; Versanis Bio $70 M Series A Financing; AC Immune’s Alzheimer’s Antibody Drug

charcot-marie-tooth-disease-market-cagr-trends-growth-size-share-forecast-therapies-therapy-therapeutics-treatment-drugs

Charcot-Marie-Tooth Disease Market Size Expects Growth Owing to Increasing Prevalence, Influx of Pharma Companies and Novel Therapies

pharma-news-and-updates-for-Ascendis-MicroTransponder-BioMarin-Zimmer-Biomet-Canary-Medical

Ascendis’s SKYTROFA; MicroTransponder’s VNS System (Vivistim); BioMarin’s Voxzogo; Zimmer-Canary’s Smart Knee Implant; COVID-19 impact on Solid Organ Transplants

recent-pharma-news-updates-for-hebabiz-pfizer-astrazeneca-bms-masimo

AstraZeneca’s Ultomiris; HebaBiz’s Siroquine; Pfizer’s XELJANZ; Bristol Myers Squibb’s Opdivo; and Masimo’s PVi

Von Hippel-Lindau Market Space Expected to Expand at a CAGR 8.3% by 2030 Owing to Increasing Prevalence and Emerging Therapies

major-depressive-disorder-key-companies-emerging-therapies-market-cagr-trends-size-share-growth-forecast

Major Depressive Disorder Market Quadrant Growth Soars Owing to Expected Launch of Key Therapies

Mounting Prevalence of Neurological Disorders and the Key Companies Bidding to Solve the Riddle

Latest-pharma-biotech-news-updates-for-gsk-pfizer-biontech-biovac-seres-therapeutics

Commencement of AAIC; GSK’s Shingles Vaccine Expanded Approval; Pfizer/ BioNtech Agreement with Biovac; Another Failure in Ulcerative Colitis Trial

Market & Competitive Assessment

Market Size & Forecast Assessment

Medical Devices

Market Research

Subscription

Competitive Intelligence

Business Consulting

Customized Solutions

Request for Proposal

Blog

Newsletter/Whitepaper

Infographics

Case Study

Events

Press Release

Analysis & Perspective